Omeros (OMER) Total Debt Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 6.94% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 50.25% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.07% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | -44.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44.90% |
| Dec 31, 2025 | -39.90% |
| Sep 30, 2025 | -38.82% |
| Jun 30, 2025 | -34.75% |
| Mar 31, 2025 | -32.32% |
| Dec 31, 2024 | -33.87% |
| Sep 30, 2024 | -33.41% |
| Jun 30, 2024 | -32.88% |
| Mar 31, 2024 | -11.90% |
| Dec 31, 2023 | -3.38% |
| Sep 30, 2023 | 10.81% |
| Jun 30, 2023 | 24.63% |
| Mar 31, 2023 | 25.24% |
| Dec 31, 2022 | 25.84% |
| Sep 30, 2022 | 26.43% |
| Jun 30, 2022 | 27.01% |
| Mar 31, 2022 | 26.86% |
| Dec 31, 2021 | 27.89% |
| Sep 30, 2021 | 33.27% |
| Jun 30, 2021 | 33.85% |
| Mar 31, 2021 | 53.95% |
| Dec 31, 2020 | 41.28% |
| Sep 30, 2020 | 40.95% |
| Jun 30, 2020 | 25.95% |
| Mar 31, 2020 | 25.81% |
| Dec 31, 2019 | 25.67% |
| Sep 30, 2019 | 30.26% |
| Jun 30, 2019 | 29.88% |
| Mar 31, 2019 | 45.37% |
| Dec 31, 2018 | 44.34% |
| Sep 30, 2018 | 66.70% |
| Jun 30, 2018 | 61.81% |
| Mar 31, 2018 | 37.48% |
| Dec 31, 2017 | 37.19% |
| Sep 30, 2017 | 36.71% |
| Jun 30, 2017 | 36.19% |
| Mar 31, 2017 | 35.83% |
| Dec 31, 2016 | 57.25% |
| Sep 30, 2016 | 51.19% |
| Jun 30, 2016 | 51.11% |
| Mar 31, 2016 | 35.32% |
| Dec 31, 2015 | 35.35% |
| Sep 30, 2015 | 48.72% |
| Jun 30, 2015 | 43.81% |
| Mar 31, 2015 | 40.12% |
| Dec 31, 2014 | 18.62% |
| Sep 30, 2014 | 29.19% |
| Jun 30, 2014 | 24.95% |
| Dec 31, 2013 | 27.63% |